Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Fitness gains hamper efforts to tackle drug resistance.

Dutta S.

Elife. 2013 Dec 10;2:e01809. doi: 10.7554/eLife.01809.

2.

Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure.

Baker S, Duy PT, Nga TV, Dung TT, Phat VV, Chau TT, Turner AK, Farrar J, Boni MF.

Elife. 2013 Dec 10;2:e01229. doi: 10.7554/eLife.01229.

3.

Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India.

Dutta S, Sur D, Manna B, Sen B, Bhattacharya M, Bhattacharya SK, Wain J, Nair S, Clemens JD, Ochiai RL.

Int J Antimicrob Agents. 2008 Apr;31(4):387-9. doi: 10.1016/j.ijantimicag.2007.12.004. Epub 2008 Feb 15. No abstract available.

PMID:
18280709
4.

Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.

Shirakawa T, Acharya B, Kinoshita S, Kumagai S, Gotoh A, Kawabata M.

Diagn Microbiol Infect Dis. 2006 Apr;54(4):299-303. Epub 2006 Feb 8.

PMID:
16466897
5.

Salmonella typhi in the democratic republic of the congo: fluoroquinolone decreased susceptibility on the rise.

Lunguya O, Lejon V, Phoba MF, Bertrand S, Vanhoof R, Verhaegen J, Smith AM, Keddy KH, Muyembe-Tamfum JJ, Jacobs J.

PLoS Negl Trop Dis. 2012;6(11):e1921. doi: 10.1371/journal.pntd.0001921. Epub 2012 Nov 15.

6.

Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.

Crump JA, Kretsinger K, Gay K, Hoekstra RM, Vugia DJ, Hurd S, Segler SD, Megginson M, Luedeman LJ, Shiferaw B, Hanna SS, Joyce KW, Mintz ED, Angulo FJ; Emerging Infections Program FoodNet and NARMS Working Groups.

Antimicrob Agents Chemother. 2008 Apr;52(4):1278-84. doi: 10.1128/AAC.01509-07. Epub 2008 Jan 22.

7.

Increasing fluoroquinolone resistance in Salmonella typhi in Ontario, 2002-2007.

Morris SK, Richardson SE, Sauve LJ, Ford-Jones EL, Jamieson F.

Am J Trop Med Hyg. 2009 Jun;80(6):1012-3.

PMID:
19478267
8.

Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia.

Yanagi D, de Vries GC, Rahardjo D, Alimsardjono L, Wasito EB, De I, Kinoshita S, Hayashi Y, Hotta H, Osawa R, Kawabata M, Shirakawa T.

Diagn Microbiol Infect Dis. 2009 Aug;64(4):422-6. doi: 10.1016/j.diagmicrobio.2009.04.006.

PMID:
19631095
9.

Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India.

Joshi S, Amarnath SK.

Trans R Soc Trop Med Hyg. 2007 Mar;101(3):308-10. Epub 2006 Sep 6.

PMID:
16950486
10.

Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.

Dimitrov T, Dashti AA, Albaksami O, Jadaon MM.

J Clin Pathol. 2010 Jan;63(1):83-7. doi: 10.1136/jcp.2009.070664. Epub 2009 Nov 3.

PMID:
19889623
11.

Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia.

Kasper MR, Sokhal B, Blair PJ, Wierzba TF, Putnam SD.

Diagn Microbiol Infect Dis. 2010 Feb;66(2):207-9. doi: 10.1016/j.diagmicrobio.2009.09.002. Epub 2009 Oct 2.

PMID:
19800753
12.

The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.

Turner AK, Nair S, Wain J.

J Antimicrob Chemother. 2006 Oct;58(4):733-40. Epub 2006 Aug 8.

PMID:
16895934
13.

Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.

Sekar U, Srikanth P, Kindo AJ, Babu VP, Ramasubramanian V.

J Commun Dis. 2003 Sep;35(3):162-9.

PMID:
15796408
14.

Salmonella enterica serovar Typhi in Japan, 2001-2006: emergence of high-level fluoroquinolone-resistant strains.

Morita M, Hirose K, Takai N, Terajima J, Watanabe H, Sagara H, Kurazono T, Yamaguchi M, Kanazawa Y, Oyaizu T, Izumiya H.

Epidemiol Infect. 2010 Mar;138(3):318-21. doi: 10.1017/S0950268809990380. Epub 2009 Jul 27.

PMID:
19631017
15.

IAP Task Force Report: management of enteric fever in children.

Kundu R, Ganguly N, Ghosh TK, Yewale VN, Shah RC, Shah NK; IAP Task Force.

Indian Pediatr. 2006 Oct;43(10):884-7. No abstract available. Erratum in: Indian Pediatr. 2006 Nov;43(11):987.

16.

Revised ciprofloxacin breakpoints for Salmonella Typhi: its implications in India.

Balaji V, Sharma A, Ranjan P, Kapil A.

Indian J Med Microbiol. 2014 Apr-Jun;32(2):161-3. doi: 10.4103/0255-0857.129804.

17.

Highly resistant Salmonella enterica serovar Typhi with a novel gyrA mutation raises questions about the long-term efficacy of older fluoroquinolones for treating typhoid fever.

Koirala KD, Thanh DP, Thapa SD, Arjyal A, Karkey A, Dongol S, Shrestha UM, Farrar JJ, Basnyat B, Baker S.

Antimicrob Agents Chemother. 2012 May;56(5):2761-2. doi: 10.1128/AAC.06414-11. Epub 2012 Feb 27.

18.

Is nalidixic acid screening still valid for the detection of reduced susceptibility of fluoroquinolone with Salmonella Typhi?

Irfan S, Jabeen K, Jilani UA, Ahmed B, Mehraj J, Ahsan T, Zafar A.

J Infect Dev Ctries. 2012 Oct 19;6(10):700-3. doi: 10.3855/jidc.1910.

19.

Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.

Nobthai P, Serichantalergs O, Wongstitwilairoong B, Srijan A, Bodhidatta L, Malla S, Mason CJ.

Southeast Asian J Trop Med Public Health. 2010 Nov;41(6):1416-22.

PMID:
21329318
20.

Antibiotic resistance of Salmonella typhi in Bangladesh.

Saha SK, Saha SK.

J Antimicrob Chemother. 1994 Jan;33(1):190-1. No abstract available.

PMID:
8157567

Supplemental Content

Support Center